Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites

Behavioural Brain Research

Volumn 228, Issue 1, 2012, Pages 30-43

  Heuer, Andreas ^a   Smith, Gaynor A ^a   Lelos, Mariah J ^a   Lane, Emma L ^b   Dunnett, Stephen B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

6 Hydroxydopamine; Dopamine; Motor behaviour; Mouse; Parkinson's disease; Striatum

Indexed keywords

AMPHETAMINE; APOMORPHINE; DOPAMINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALANCE BEAM TEST; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; CORRIDOR TEST; CYLINDER TEST; DOPAMINERGIC NERVE CELL; EXPERIMENTAL TEST; GAIT; INVERTED CAGE LID TEST; MALE; MEDIAL FOREBRAIN BUNDLE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; ROTATION; STAIRCASE TEST; STEPPING TEST; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; MEDIAL FOREBRAIN BUNDLE; MICE; MICE, INBRED C57BL; MICROINJECTIONS; MOTOR SKILLS; NERVE DEGENERATION; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 83655192207     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.11.027     Document Type: Article

References (52)

1. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008, 79:368-376.
2. Bove J., Prou D., Perier C., Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2005, 2:484-494.
3. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
4. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
5. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1968, 5:107-110.
6. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970, 24:485-493.
7. Rodriguez Diaz M., Abdala P., Barroso-Chinea P., Obeso J., Gonzalez-Hernandez T. Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease. Behav Brain Res 2001, 122:79-92.
8. Schwarting R.K., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 1996, 50:275-331.
9. Schwarting R.K., Huston J.P. Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology 1997, 18:689-708.
10. Lundblad M., Picconi B., Lindgren H., Cenci M.A. A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 2004, 16:110-123.
11. Lundblad M., Usiello A., Carta M., Hakansson K., Fisone G., Cenci M.A. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Exp Neurol 2005, 194:66-75.
12. Francardo V., Recchia A., Popovic N., Andersson D., Nissbrandt H., Cenci M.A. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to l-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol Dis 2011.
13. Grealish S., Mattsson B., Draxler P., Bjorklund A. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci 2010, 31:2266-2278.
14. Baird A.L., Meldrum A., Dunnett S.B. The staircase test of skilled reaching in mice. Brain Res Bull 2001, 54:243-250.
15. Mandel R.J., Randall P.K. Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse. Brain Res 1985, 330:358-363.
16. Iancu R., Mohapel P., Brundin P., Paul G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 2005, 162:1-10.
17. Francardo V., Recchia A., Popovic N., Andersson D., Nissbrandt H., Cenci M.A. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to l-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol Dis 2011, 42:327-340.
18. Montoya C.P., Campbell-Hope L.J., Pemberton K.D., The Dunnett S.B. staircase test: a measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods 1991, 36:219-228.
19. Smith G.A., Heuer A. 6-OHDA toxin models of PD in mice. Contemporary Animal Models with Movement Disorders 2011, Springer/Humana, UK. E.L. Lane, S.B. Dunnett (Eds.).
20. Dowd E., Monville C., Torres E.M., Dunnett S.B. The corridor task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum. Brain Res Bull 2005, 68:24-30.
21. Allbutt H.N., Henderson J.M. Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease. J Neurosci Methods 2007, 159:195-202.
22. Brooks S., Higgs G., Janghra N., Jones L., Dunnett S.B. Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL/6J) Huntington's disease transgenic mice. Brain Res Bull 2010.
23. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
24. Alvarez-Fischer D., Henze C., Strenzke C., Westrich J., Ferger B., Hoglinger G.U., et al. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Exp Neurol 2008, 210:182-193.
25. Monville C., Torres E.M., Dunnett S.B. Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods 2006, 158:219-223.
26. Ogura T., Ogata M., Akita H., Jitsuki S., Akiba L., Noda K., et al. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. Neurosci Res 2005, 51:299-308.
27. Olsson M., Nikkhah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995, 15:3863-3875.
28. Blume S.R., Cass D.K., Tseng K.Y. Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism. Exp Neurol 2009, 219:208-211.
29. de Medinaceli L., Freed W.J., Wyatt R.J. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 1982, 77:634-643.
30. Richter F., Hamann M., Richter A. Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice. Brain Res 2008, 1188:148-156.
31. Brooks S.P., Dunnett S.B. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 2009, 10:519-529.
32. Brooks S.P., Pask T., Jones L., Dunnett S.B. Behavioural profiles of inbred mouse strains used as transgenic backgrounds. I: motor tests. Genes Brain Behav 2004, 3:206-215.
33. Dunnett S.B., Torres E.M., Annett L.E. A lateralised grip strength test to evaluate unilateral nigrostriatal lesions in rats. Neurosci Lett 1998, 246:1-4.
34. Steiner H., Kitai S.T. Unilateral striatal dopamine depletion: time-dependent effects on cortical function and behavioural correlates. Eur J Neurosci 2001, 14:1390-1404.
35. Costall B., Marsden C.D., Naylor R.J., Pycock C.J. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Res 1976, 118:87-113.
36. Schmidt J., Westermann K.H. Effects of preceding sensibilization by reserpine and haloperidol on toxicity of dopaminergic agonists. Arch Toxicol Suppl 1980, 4:479-481.
37. Dowd E., Dunnett S.B. Deficits in a lateralized associative learning task in dopamine-depleted rats with functional recovery by dopamine-rich transplants. Eur J Neurosci 2004, 20:1953-1959.
38. Cenci M.A., Lundblad M. Ratings of l-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Curr Protoc Neurosci 2007, 25. Chapter 9: unit 9.
39. Smith G.A., Heuer A., Dunnett S.B., Lane E.L. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia. Behav Brain Res 2012, 226:281-292.
40. Blandini F., Levandis G., Bazzini E., Nappi G., Armentero M.T. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 2007, 25:397-405.
41. Kirik D., Rosenblad C., Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 1998, 152:259-277.
42. Torres E.M., Dunnett S.B. Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's disease. Eur Neuropsychopharmacol 2007, 17:206-214.
43. Randall P.K. Lesion-induced DA supersensitivity in aging C57BL/6J mice. Brain Res 1984, 308:333-336.
44. Von Voigtlander P.F., Moore K.E. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, l-DOPA, amanthadine, amphetamine and other psychomotor stimulants. Neuropharmacology 1973, 12:451-462.
45. Hefti F., Melamed E., Sahakian B.J., Wurtman R.J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav 1980, 12:185-188.
46. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999, 19:3248-3257.
47. Schallert T., Whishaw I.Q., Ramirez V.D., Teitelbaum P. Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats. Science 1978, 199:1461-1463.
48. Abrous D.N., Shaltot A.R., Torres E.M., Dunnett S.B. Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: effects on drug-induced behaviours and skilled paw-reaching. Neuroscience 1993, 53:187-197.
49. Kelly P.H., Moore K.E. Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats. Psychopharmacology (Berl) 1977, 55:35-41.
50. Kelly P.H. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats. Brain Res 1975, 100:163-169.
51. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 1975, 94:507-522.
52. Dowd E., Dunnett S.B. Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats. Behav Brain Res 2005, 159:153-161.